Our radioligand R&D facility

PIRI: POINT Institute for Radioligand Innovation

Located in Toronto, Canada, PIRI is POINT’s state of the art GMP R&D center, focused on bringing novel programs from discovery to the clinic.

A couple standing together, smiling.

Licensed for alpha, beta, gamma, and positron emitters

Enables on-site research and development with a wide variety of imaging and therapeutic isotopes.

On-site cyclotron & hot cells

GE PETtraceTM 800 cyclotron and hot cells enable on-site production of many medical isotopes.

Located in a translational institute and research hospital network

PIRI is located in Toronto General Hospital, which is part of the largest health research organization in Canada, the University Hospital Network (UHN), facilitating rapid translation into the clinic.